,Obstetrics and Gynecology
D D
PreTest Self-Assessment D and D Review
TM D
, Notice
Medicine D is D an D ever-changing D science. D As D new D research D and D clinical D
experience D broaden D our D knowledge, D changes D in D treatment D and D drug D
therapy D are D required. D The D authors D and D the D publisher D of D this D work D have D
checked D with D sources D believed D to D be D reliable D in D their D efforts D to D provide
D information D that D is D complete D and D generally D in D accord D with D the D
standards D accepted D at D the D time D of D publication. D However, D in D view D of D the D
possibility D of D human D error D or D changes D in D medical D sciences, D neither D the D
authors D nor D the D publisher D nor D any D other D party D who D has D been D involved D
in D the D preparation D or D publication D of D this D work D warrants D that D the D
information D contained D herein D is D in D every D respect D accurate D or D complete, D
and D they D disclaim D all D responsibility D for D any D errors D or D omissions D or D for D
the D results D obtained D from D use D of D the D information D contained D in D this D
work. D Readers D are D encouraged D to D confirm D the D information D contained D
herein D with D other D sources. D For D example D and D in D particular, D readers D are D
advised D to D check D the D prod- D uct D information D sheet D included D in D the D
package D of D each D drug D they D plan D to D administer D to D be D certain D that D the D
information D contained D in D this D work D is D accurate D and D that D changes D have D
not D been D made D in D the D recommended D dose D or D in D the D contraindications D
for D administration. D This D recommendation D is D of D particular D importance D in D
connection D with D new D or D infrequently D used D drugs.
, Obstetrics and Gynecology D D
PreTest Self-Assessment D and D Review D
TM D
Twelfth DEdition
Karen D M. DSchneider, DMD
Associate D Professor
Department D of D Obstetrics, D Gynecology, D and D Reproductive D
Sciences D University D of D Texas D Houston D Medical D School
Houston, D Texas
Stephen D K. DPatrick, DMD D
Residency D Program D Director D
Obstetrics D and D Gynecology
The D Methodist D Health D System D
Dallas D Dallas, D Texas
New D York D Chicago D San D Francisco D Lisbon D London D
Madrid D Mexico D City D Milan D New D Delhi D San D Juan D
Seoul D Singapore D Sydney D Toronto
D D
PreTest Self-Assessment D and D Review
TM D
, Notice
Medicine D is D an D ever-changing D science. D As D new D research D and D clinical D
experience D broaden D our D knowledge, D changes D in D treatment D and D drug D
therapy D are D required. D The D authors D and D the D publisher D of D this D work D have D
checked D with D sources D believed D to D be D reliable D in D their D efforts D to D provide
D information D that D is D complete D and D generally D in D accord D with D the D
standards D accepted D at D the D time D of D publication. D However, D in D view D of D the D
possibility D of D human D error D or D changes D in D medical D sciences, D neither D the D
authors D nor D the D publisher D nor D any D other D party D who D has D been D involved D
in D the D preparation D or D publication D of D this D work D warrants D that D the D
information D contained D herein D is D in D every D respect D accurate D or D complete, D
and D they D disclaim D all D responsibility D for D any D errors D or D omissions D or D for D
the D results D obtained D from D use D of D the D information D contained D in D this D
work. D Readers D are D encouraged D to D confirm D the D information D contained D
herein D with D other D sources. D For D example D and D in D particular, D readers D are D
advised D to D check D the D prod- D uct D information D sheet D included D in D the D
package D of D each D drug D they D plan D to D administer D to D be D certain D that D the D
information D contained D in D this D work D is D accurate D and D that D changes D have D
not D been D made D in D the D recommended D dose D or D in D the D contraindications D
for D administration. D This D recommendation D is D of D particular D importance D in D
connection D with D new D or D infrequently D used D drugs.
, Obstetrics and Gynecology D D
PreTest Self-Assessment D and D Review D
TM D
Twelfth DEdition
Karen D M. DSchneider, DMD
Associate D Professor
Department D of D Obstetrics, D Gynecology, D and D Reproductive D
Sciences D University D of D Texas D Houston D Medical D School
Houston, D Texas
Stephen D K. DPatrick, DMD D
Residency D Program D Director D
Obstetrics D and D Gynecology
The D Methodist D Health D System D
Dallas D Dallas, D Texas
New D York D Chicago D San D Francisco D Lisbon D London D
Madrid D Mexico D City D Milan D New D Delhi D San D Juan D
Seoul D Singapore D Sydney D Toronto
